ArticleCancer science2017

Glucose metabolism-targeted therapy and withaferin A are effective for epidermal growth factor receptor tyrosine kinase inhibitor-induced drug-tolerant persisters.

Kei Kunimasa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.